ici 118551 and bucindolol

ici 118551 has been researched along with bucindolol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, JG; Fretwell, L; Gardiner, SM; Hill, SJ; Kemp, P; March, J	1

Other Studies

1 other study(ies) available for ici 118551 and bucindolol

Article	Year
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:12 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Heart Rate; Humans; Imidazoles; Isoproterenol; Male; Phenoxyacetates; Phenoxypropanolamines; Propanolamines; Rats; Rats, Sprague-Dawley; Vascular Resistance; Xamoterol	2011

Article

Year

Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:12

Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Heart Rate; Humans; Imidazoles; Isoproterenol; Male; Phenoxyacetates; Phenoxypropanolamines; Propanolamines; Rats; Rats, Sprague-Dawley; Vascular Resistance; Xamoterol

2011